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ABSTRACT 
Background:  Functional  food  can  be  a  potent  source  of  wide  array  of  biocomonents  with 
antimicrobial activity. We investigated the antibacterial activity of red cabbage (RC) extract on 
Gram negative and positive ATCC strains. Most intersting, we, for the first time, explored and 
analysed  the  complete  phenotypic  profile  of  RC-treated  bacteria  using  Omnilog  Phenotype 
Microarray.  
 
Results: This study revealed that the phenotype microarray (PM) screen was a valuable tool in 
the search for compounds and their antibacterial mechanisms that can inhibit bacterial growth by 
affecting certain metabolic pathways. It was shown that RC exerted remarkable antibacterial 
effect on S. aureus and E. coli bacteria, and PM showed a wide range phenotypic profile of the 
exerted RC antibacterial activity. RC targeted the peptide, carbon, nutriontional assembly, and 
sulfur metbolic pathways altogether. The peptidoglycan synthesis pathway was inferred to be 
targeted by RC extract at a metabolic point different from other available cell wall-targeting 
drugs;  these  could  be  hot  targets  for  the  discovery  of  new  therapy  for  many  problematic 
microbes.  
 
Conclusions: Taken together, the phenotype microarray for functional food and medicinal plants 
can  be  a  very  useful  tool  for  profiling  their  antimicrobial  activity.  Moreover,  extracts  of 
functional food can exert antibacterial activity by hitting a wide range of metabolic pathways, at 
the  same  time  leading  to  very  difficult  condition  for  bacteria  to  rapidly  develop  resistance. 
Therefore, using functional foods or medicinal plants as such, or as extracts, can be superior on 
mono-targeting antibiotics if the optimal concentrations and conditions of these functional foods 
were sought.  
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BACKGROUND: 
The continuous escalation of resistant bacteria and fungi against a wide range of antibiotics, and 
the indiscriminate use of  antimicrobial drugs in the treatment of infectious diseases, have caused 
many microorganisms to develop resistance to several antibiotics; this necessitates the discovery 
of novel and unconventional sources of antibiotics [1]. Therefore, there is a critical need to move 
quickly and develop alternative antimicrobial drugs from natural products and functional foods. 
One approach is to screen local medicinal plants, or functional foods, which represent a rich 
source of novel antimicrobial agents.  
In  the  past  few  decades,  plant  phenolic  metabolites  have  gained  interest  due  to  their 
potential  role  in  the  prevention  and  treatment  of  human  diseases.  In  addition,  the  use  of 
phytochemicals  as  natural  antimicrobial  agents,  commonly  called  ‘biocides’,  is  gaining 
popularity [2]. Interestingly, natural phenolic agents from plants may have a major advantage 
since they might contain a spectrum of phenolic antimicrobials, instead of a single antimicrobial 
substance,  directed  toward  a  certain  spectrum  of  microbes  which  potentially  be  ineffective 
against the ‘antibiotic resistance’ phenomenon commonly seen with long-term use of synthetic 
antibiotics [3].  It is noteworthy to mention that flavonoids have been associated with many of 
the biological effects such as antibacterial, antiviral, anti-inflammatory, antiplatelet, antioxidant, 
free radical scavenging, vasodilatory actions, and the ability to lower the risk of coronary heart 
diseases [4]. Accordingly, some plant phenolics are being developed as potential antimicrobial 
agents and used in the defense against human pathogens [5, 6]. Besides, synthetic chemicals, 
which have long been used as active agents in reducing the incidence of  diseases in plants, 
animals and humans, are costly and loaded with side effects [1]. Therefore, the need for more 
research on new sources, such as medicinal plants and functional food, has become necessary to 
provide the society with cheap and effective alternative medical drugs. Such medicinal plant 
products are believed to be highly crucial to improve the society health level and prevent the 
development of serious diseases [7].  
Red cabbage (Brassica oleracea L. var. capitata f. rubra DC), which belongs to the family 
Brassicaceae, is one of the most important vegetables grown worldwide. Recently, red cabbage 
has attracted much attention because of its physiological functions and applications. The dye of 
red cabbage has been used as a pH indicator in pharmaceutical formulations, [8] and as a food 
colorant in food systems [9]. There were some studies conducted on red cabbage extract proving 
its ability to suppress the oxidative stress in vivo [10, 11], anticancer [12], anti-inflammatory 
[13],  and anti-diabetic effects [14]. However, only two studies on the antibacterial effects of red 
cabbage extract and juice were found worldwide [12, 15]. 
Among  the  substances  that  seem  to  be  responsible  for  the  biological  activities  of  red 
cabbage, are polyphenols [16]. Red cabbage is a rich source of phenolic compounds, with the 
anthocyanins  being  predominant  over  other  flavonoids  [16,  17].  The  highest  stability  and 
strongest antioxidative properties in red cabbage extract were assigned to anthocyanins [18]. To 
date,  about  36  anthocyanins  have  been  identified  in  red  cabbage  [19].  The  amount  of  total 
anthocyanins in red cabbage was found to be positively correlated with total antioxidant power, 
implicating  the  potential  of  health  benefit  of  red  cabbage  to  human  health.  The  content  of 
phenolic compounds and the antioxidant activity are partly dependent on the color of the variety 
of the vegetables. The very high values of antioxidant activity were found in intensely colored Functional Foods in Health and Disease 2012, 2(6):212-227                                                            Page 214 of 227 
vegetables like red cabbage, red onion, etc. [20, 21]. Besides flavonoids, the antioxidant activity 
in  cruciferous vegetables,  such as  red cabbage,  has  also  been associated with  glucosinolates 
which  present in high quantities [16].  
 
METHODS: 
Preparation of the Stock Extract: The stock extract of RC was prepared by redissolving the 
extract in methanol for the preparation of disc diffusion assay [22]. On the other hand, extracts 
were dissolved in dimethyl sulfoxide (DMSO) 10%, (BIO BASIC INC., NY, USA). At this 
concentration,  DMSO  was  shown  to  be  non  toxic  to  microorgansims.  It  was  used  for  the 
preparation of microdilution assay, electron microscope observations,  and Biolog microarray 
assay [23]. The dissolved suspension was centrifuged at 134 g for 10min and filtrated by 0.45 
μm  Millipore  filters  (Nalgene,  UK).  The  stock  was  stored  at  -20°C  until  further  use.  The 
concentration of the stock extract was determined as required in each section. 
 
Disc  Diffusion  Assay:  Briefly,  the  stock  extracts  were  prepared  at  200  and  500  mg/ml  for 
antibacterial tests. The primary screening antimicrobial test was carried out by using the disc 
diffusion assay [24]. The bacteria were cultured in Nutrient Broth (Merck, Darmstadt, Germany) 
for 24h at 37°C. One hundred microliter of suspension containing 10
8 CFU/ml  were spread 
evenly on the surface of the nutrient agar. Sterile Whatman No. 1 filter paper (MACHEREY-
NAGEL, MN 615, Germany) was used to prepare 6 mm in diameter discs. Ten microliters of the 
samples with the concentrations of 200, 500, and 700 mg/ml of the plant extracts were loaded 
into  the  discs  in  triplicate  in  order  to  give  final  concentrations  of  2,  5,  and  7  mg/disc, 
respectively. These discs were then impregnated in the inoculated agar. The inoculated plates 
were incubated for 24h at 37°C. Clear inhibition zones around discs indicated the presence of 
antimicrobial activity. More details are described in another report from our team [25]  
 
Microdilution Assay: The minimum inhibitory concentration (MIC) values were assessed for 
the microorganisms which were shown to be sensitive to the extract by the disc diffusion assay. 
The microdilution method was used according to the methodology referred by Zgoda and Porter 
(2001) [26] with some modifications [25]. The inocula of the bacteria were prepared from 12h 
broth  cultures  and standardized to  10
8  CFU/ml. To confirm  MIC and to  establish  minimum 
bactericidal concentrations (MBC), 10 µl of each culture medium for bacteria with no visible 
growth  were  removed  from  each  well  and  inoculated,  in  triplicates,  on  nutrient  agar.  After 
incubation for 24h at 37°C, the number of surviving organisms was determined [25].  
  
Transmission Electron Microscope (TEM): Transmission electron microscope observations 
were carried out on E. coli (ATCC 25922) and S. aureus (ATCC 29247) as an example for the 
extract effect on the bacterial cells of Gram negative and Gram positive bacteria. The inocula of 
the bacteria were prepared from 12h nutrient broth cultures and standardized to 10
8 CFU/ml. The 
stock extract was to a concentration of 200 mg/ml. One milliliter of 10
8 CFU/ml of S. aureus and 
E. coli bacteria suspensions were incubated with 1 ml extract solution at final concentration 100 
mg/ml for 24h at 37°C. The detailed procedure of TEM is described by our team in another 
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Biolog Phenotype Microarray Technology: The phenotype analysis was carried out by using a 
new tool, Phenotype MicroArrays (PMs). Biolog’s Phenotype MicroArray technology (Biolog, 
USA) offers a unique way to identify natural product hits and to infer a mode of action by which 
the novel inhibitor (the extract) prevents microbial growth [27]. The assays are pre-filled and 
dried in 96-well microplates that can monitor chemical sensitivities. Cell response in each assay 
well  is  determined  by  the  amount  of  color  development  produced  by  the  reduction  of  a 
tetrazolium compound (a redox indicator) during cell respiration [28]. To identify the method of 
action of RC extract on Gram negative and Gram positive bacteria, PMs were employed to 
screen various sources of carbon, nitrogen, sulfur and phosphorous. PMs 1-8 were used in which 
PM1 and 2 measures carbon utilization phenoytpe while PM3 to 8 measures nitrogen, sulfur and 
phosphorous utilization phenotypes. The methods were done according to the PM procedure for 
E. coli and other Gram negative bacteria and the PM procedure for B. subtilis and other Gram 
positive  bacteria  provided  by  Biolog  Inc.,  USA.  All  the  fluids,  PMs,  and  instruments  were 
purchased  from  Biolog  Inc.,  USA.  Kinetic  data  were  analyzed  with  OmniLog  PM  software 
(Biolog, USA). The results were expressed by the differences of the treated bacterial cells from 
untreated bacterial cells (control group). 
  
PMs of RC Extract with E. Coli: E. coli (ATCC 25922) was grown overnight at 37°C on 
nutrient agar plates. In order to prepare the control group bacteria (untreated bacteria), colonies 
were harvested from the surface of an agar plate with a sterile cotton wool swab and suspended 
in 16 ml of Inoculating Fluid-0a (IF-0a), in a 20 ml sterile capped glass tube. The cell density 
must be equaled to 42% transmittance (T) on a Biolog turbidimeter. The IF-0a with Biolog 
Redox Dye Mix A was prepared by adding 0.9 ml of Dye Mix A to 62.5 ml of IF-0a and 
completed the volume to 75 ml by sterile distilled water. To prepare the bacterial cell suspension, 
15 ml of IF-0a with bacteria was added to 75 ml of IF-0a with Dye Mix A; the cell density must 
be 85% T. Later, 22 ml of this 85% T suspension were transferred to a sterile reservoir and 100 
μl/well using Biolog multichannel pipette were added to PM1 and 2 plates. D-glucose (Sigma, 
Steinheim, Germany) with concentration of 20 mM was added as a carbon source to the rest of 
85% cell suspension in order to inoculate PM3 to 8 plates with 100 μl/well. To prepare the 
treated group bacteria (bacteria treated by RC extract), the same previous steps were followed 
except the addition of RC extract (100 mg/ml) instead of distilled water in IF-0a plus Dye Mix 
A.  All the plates were incubated at 37°C in the OmniLog plate incubator and reader and were 
monitored for any color change of the wells. Readings were recorded for 48h for all PM plates.  
 
PMs of RC Extract with S. Aureus: S. aureus (ATCC 29247) was grown on nutrient agar 
plates overnight at 37°C. In order to prepare the control  group bacteria (untreated bacteria), 
colonies were harvested from the surface of an agar plate with a sterile cotton wool swab and 
suspended in 16 ml of Inoculating Fluid-0a (IF-0a), in a 20 ml sterile capped glass tube. The cell 
density must be equaled to 81% transmittance (T) on a Biolog turbidimeter. To enhance the 
Gram positive bacterial growth some additives were added to PMs inocula. Each PM plate needs 
its own PM additive (see below) which was prepared as 120x stock solution final volume 100ml, 
sterilized by filtration using 0.22 μm Millipore filters (Nalgene, UK) and stored at 4°C till further 
use. All the chemicals used in PM additives were purchased from Sigma, Steinheim, Germany. Functional Foods in Health and Disease 2012, 2(6):212-227                                                            Page 216 of 227 
To prepare the inocula for PM plates, four plastic tubes (50ml) were used. The first tube was for 
PM1 and 2. The second one was for PM3, 6, 7 and 8. The third and the fourth tubes were for 
PM4 and 5, respectively. To prepare the inocula for PM1 and 2, the following additions were 
done. Twenty milliliter of IF-0a (1.2x) were added and mixed with 0.24 ml Dye Mix F (100x). 
Two milliliter of PM1 and 2 additives (120x) were also added to give final concentration of 12x. 
PM1 and 2 additives (120x) were composed of the following ingredients: 10 ml of (240 mM of 
MgCl2. 6H2O with 120 mM of CaCl2.2H2O), 10 ml of (3 mM of L-arginine.HCl with 6 mM of 
L-glutamic  acid),  30  ml  of  (1  mM  of  L-cystine  pH8.5  with  1  mM  of  Uridine  5`-
monophosphat.2Na), 10 ml of 0.6% yeast extract, 10 ml of 0.6% Tween-80 and 30 ml sterile 
distilled water. Later, the bacterial cell suspension was added as 1.76 ml to PM1 and 2 tube, and 
the inoculum was ready to inoculate PM1 and 2 plates with 100 μl/well. For the preparation of 
PM3,6,7 and 8 inocula, 40 ml of  IF-0a (1.2x) were added to the second tube and mixed with 
0.48 ml Dye Mix F (100x).  Four milliliter of PM additives specific for these panels were added 
from 120x stock to give final concentration of 12x. PM3, 6, 7, and 8 additive stock solution was 
composed of the following: 30 ml of (800 mM of tricarballylic acid, pH 7.1), 10 ml of (240 mM 
of MgCl2.6H2O with 120 mM of CaCl2.2H2O), 30 ml of (1 mM of L-cystine pH8.5 with 1 mM 
of Uridine 5`-monophosphat.2Na), 10 ml of 0.6% yeast extract, 10 ml of 0.6% Tween-80, and 10 
ml of (300 mM of D-glucose with 600 mM of sodium pyruvate). A cell suspension of 3.52 ml 
was added to this tube (tube for PM3,6,7, and 8 inocula) and the inoculum was ready to be 
applied to PM3, 6, 7, and 8 plates as 100 μl/well. Finally, to prepare PM4 and 5 inocula, 10 ml of 
IF-0a (1.2x) were added to each specified tube then mixed with 0.12 ml Dye Mix F (100x). One 
milliliter of PM4 and 5 additives was added from 120x stock solution to give final concentration 
of  12x.  PM4  additive  solution  was  composed  of  the  following:  30  ml  of  (800  mM  of 
tricarballylic acid, pH 7.1), 10 ml of (240 mM of MgCl2.6H2O with 120 mM of CaCl2.2H2O), 10 
ml of (3 mM of L-arginine.HCL with 6 mM of L-glutamic acid), 10 ml of 0.6% yeast extract, 10 
ml of 0.6% Tween-80 and 10 ml of (300 mM of D-glucose with 600 mM of sodium pyruvate) 
and 20 ml of sterile distilled water. While PM5 additive solution was composed of: 30 ml of (800 
mM  of  tricarballylic  acid,  pH  7.1),  10  ml  of  (240  mM  of  MgCl2.6H2O  with  120  mM  of 
CaCl2.2H2O), 10 ml of (300 mM of D-glucose with 600 mM of sodium pyruvate) and 50 ml of 
sterile distilled water. Then 0.88 ml of bacterial cell suspension was added to each tube of PM4 
and 5 and the inocula were ready to inoculate PM4 and 5 plates as 100 μl/well. Regarding the 
S.aureus  treated  with  RC  extract,  the  extract  solution  was  prepared  as  100  mg/ml  final 
concentration. All the steps were the same as for the control group except the addition of the 
extract solution to each PM inoculum. One milliliter of RC extract was added to the prepared 
PM1,2,4 and 5 inocula. While 2 ml of RC extract were added to the prepared PM3,6,7 and 8 
inocula. All the plates were inoculated as 100 μl/well. The plates were incubated at 37°C in the 
OmniLog  plate  incubator  and  reader  and  were  monitored  for  color  changes  in  the  wells. 
Readings were recorded for 48h for all PM plates.  
 
RESULTS: 
Antibacterial  Activity  of  Red  Cabbage:  The  extract  of  red  cabbage  showed  remarkable 
antibacterial  activity  toward  both  Gram  negative,  namely  E.  coli  ATCC  strain,  and  Gram Functional Foods in Health and Disease 2012, 2(6):212-227                                                            Page 217 of 227 
positive,  namely  S.  aureus  ATCC  strain.  The  antibacterial  level  of  RC  shown  through  disc 
diffusion and microdilution assay is shown in tables 1 and 2, respectively. 
 
Table 1: Antibacterial activity of RC against S. aureus and E. coli ATCC strains via disc 
diffusion assay 
 
Microorganisms  Inhibition zone in diameter (mm) 
Bacterial 
species 
Number of 
strains 
B.oleracea methanol extract 
(mg/ml) 
 
200               500 
Negative 
control 
(MeOH
*) 
Positive control 
(streptomycin 10 
µg/disc) 
           
S. aureus 
1 (ATCC 
29247 stain) 
-  11  1.3  -  17  0.8 
E. coli 
1 (ATCC 
25922 strain) 
15  1.1  20  1.0  -  11  0.3 
           
 
 
Table 2. The MIC and MBC values of RC extract against S. aureus and E. coli ATCC strains by 
microdilution method 
 
Bacterial species 
Number of 
strains 
MIC
* 
(mg/ml) 
MBC
†  
(mg/ml) 
MBC: 
MIC 
ratio 
Antibacterial 
Mode 
Positive control 
streptomycin 
(μg/ml) 
MIC         MBC 
S. aureus 
1 (ATCC 
29247 stain) 
100  400  4: 1  Bacteristatic  0.06  0.1 
E. coli 
1 (ATCC 
25922 strain) 
100  400  4: 1  Bacteristatic  0.045  0.09 
               
 
Transmission  Electron  Microscopy:  The  antibacterial  effect  observed  by  TEM  was 
demonstrated as clear morphological changes in the treated cells along with detachment of the 
cell membrane (Figure 1). 
 
Phenotype Microarray for E. coli and S. aureus Bacteria Treated with RC Extract: In the 
field  of  drug  discovery,  the  Phenotype  MicroArray  (PM)  allows  researchers  to  obtain  a 
comprehensive picture of a drug's effect on a specific cell [27]. With PM technology, the drug, or 
the extract of a functional food, can be incubated with bacterial cells; then, information-rich 
fingerprint for the phenotypic profile of the treated bacterial cells is created showing the effect of 
that drug on the metabolic pathways and functionality of the treated bacterial cells [28]. Due to 
the large number of substrates used in the PM technology, the phenotypic profiling for the effect 
of drugs  or extracts used on certain  bacterial cells  is  unique and highly  informative  for the 
possible modes of actions of the tested antibacterial agents [27, 28].   
The OmniLog PM software detected many phenotype differences between PMs of treated 
and the untreated bacterial cells of E. coli and S. aureus with RC extract (Tables 3 and 4). Functional Foods in Health and Disease 2012, 2(6):212-227                                                            Page 218 of 227 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Photos by transmission electron microscope study of S. aureus and E. coli treated with 
RC  methanol  extract  showing  the  cytological  changes  in  S.  aureus  cells:  (A)  control  cells: 
magnification 100.000k (B) treated cells: magnification 100.000k and in E. coli cells: (C) control 
cells: magnification 60.000k (D) treated cells: magnification 60.000k 
 
Bacteria  were  exposed  to  extracts  at  minimal  inhibitory  concentrations  and  phenotype 
monitoring  by  OmniLog  PM  was  then  conducted.  PM  tests  were  performed  in  96-well 
microplates containing different nutrients necessary for the growth of Gram negative and Gram 
positve bacteria. The differences were calculated when OmniLog PM software system detected 
growth in the wells of untreated cells and no growth in the corresponding extract-treated wells. 
These  differences  were  due  to  the  effect  of  the  extract  by  inhibiting  a  particular  metabolic 
pathway which needs and uses the coated nutrient on the well. The differences were detected 
colorimetrically. The results which were expressed as negative values indicate that the control 
wells had greater rate of respiration than the treated wells. No positive values were detected; 
positive values indicate that the treated wells had greater rate of respiration than the control 
wells.  The  inhibition  rate  of  RC  extract  on  both  E.  coli  and  S.  aureus  growth  was  highly 
manifested in the PM plates with peptide metabolites as nitrogen source, then followed by PM 
plates with metabolites as carbon source. The level of inhibition in the RC-treated plates was 
shown  to  be  as  follows:  nitrogen  source  (peptide  group)  >  carbon  source  >  nutritional 
supplement group > other nitrogen source group > phosphorus group > sulfur group.  
D 
A 
C 
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Table 3: The profile of suppressed growth of RC-treated E. coli with the target substrate and the 
implicated metabolic mode of action.  
Plate type  Well number  *Biolog reading  Substrate 
Mode of action: C-Source, carbohydrate group: 
PM1  A02  -78  L-Arabinose 
PM1  A03  -45  N-Acetyl-D Glucosamine 
PM1  B02  -134  D-Sorbitol 
PM1  B03  -46  Glycerol 
PM1  B04  -103  L-Fucose 
PM1  B11  -95  D-Mannitol 
PM1  C01  -111  D-Glucose-6-Phosphate 
PM1  C07  -75  D-Fructose 
PM1  E03  -101  D-Glucose-1-Phosphate 
PM1  E04  -42  D-Fructose-6-Phosphate 
PM1  H05  -77  D-Psicose 
PM2A  B01  -45  N-Acetyl-D Galactosamine 
PM2A  B03  -87  β-D-Allose 
PM2A  D01  -64  D-Raffinose 
PM2A  D04  -78  L-Sorbose 
PM2A  D05  -97  Stachyose 
PM2A  E05  -96  D-Glucosamine 
PM2A  F03  -69  Melibionic Acid 
Mode of action: C-Source, carboxylic acid group: 
PM1  C02  -108  D-Galactonic  Acid-γ Lactone 
PM1  C03  -84  D,L-Malic Acid 
PM1  D03  -49  D-Glucosaminic Acid 
PM1  F05  -63  Fumaric Acid 
PM1  F06  -68  Bromo Succinic Acid 
PM1  G07  -67  Acetoacetic Acid 
PM1  G12  -72  L-Malic Acid 
PM1  H02  -87  p-Hydroxy Phenyl Acetic Acid 
PM1  H03  -94  m-Hydroxy Phenyl Acetic Acid 
Mode of action: C-Source, amino acid group: 
PM1  B01  -89  D-Serine 
PM1  D01  -55  L-Asparagine 
PM1  E01  -94  L-Glutamine 
PM1  F01  -65  Glycyl-L-Aspartic Acid 
PM1  F04  -87  D-Theonine 
PM1  G03  -88  L-Serine 
PM1  H01  -59  Glycyl-L-Proline 
PM2A  G03  -116  N-Acetyl-L glutamic Acid 
PM3B  A12  -76  L-Glutamic Acid 
PM3B  C03  -248  D-Alanine 
PM6  A02  -281  L-Glutamine 
Mode of action: C-Source, alcohol group: 
PM1  D04  -76  1,2-Propanediol 
Mode of action: C-Source, polymer group: 
PM2A  A06  -87  Dextrin 
Mode of action: N-Source, inorganic group: 
PM3B  A02  -152  Ammonia 
PM3B  A03  -53  Nitrite 
Mode of action: Other N-Source group: 
PM3B  A06  -70  Biuret 
PM3B  F01  -70  N-Acetyl-D Mannosamine 
PM3B  F02  -113  Adenine 
PM3B  F03  -261  Adenosine Functional Foods in Health and Disease 2012, 2(6):212-227                                                            Page 220 of 227 
PM3B  F04  -104  Cytidine 
PM3B  G02  -94  Xanthosine 
Mode of action: P-Source, inorganic group: 
PM4A  A02  -155  Phosphate 
Mode of action: P-Source, organic group: 
PM4A  B02  -167  Dithiophosphate 
PM4A  B03  -231  D,L-α-Glycerol Phosphate 
PM4A  C01  -195  Phosphoenol Pyruvate 
PM4A  C03  -118  D-Glucose-1-Phosphate 
PM4A  D01  -161  D-Mannose-1-Phosphate 
PM4A  D02  -141  D-Mannose-6-Phosphate 
PM4A  D03  -184  Cysteamine-S Phosphate 
PM4A  D04  -193  Phospho-L Arginine 
Mode of action: S-Source, inorganic group: 
PM4A  F02  -170  Sulfate 
PM4A  F03  -201  Thiosulfate 
Mode of action: S-Source, organic group: 
PM4A  G02  -64  S-Methyl-L Cysteine 
PM4A  G03  -145  Cystathionine 
PM4A  H01  -131  L-Djenkolic Acid 
PM4A  H02  -50  Thiourea 
Mode of action: Nutritional supplement group: 
PM5  A09  -90  Adenosine-3’,5’-cyclic Monophosphate 
PM5  B05  -156  L-Leucine 
PM5  B09  -159  Guanosine-3’,5’- cyclic Monophosphate 
PM5  B10  -196  Guanine 
PM5  B11  -195  Guanosine 
PM5  D10  -56  Cytosine 
PM5  D11  -169  Cytidine 
PM5  E08  -174  D-Pantothenic Acid 
PM5  E09  -153  Orotic Acid 
PM5  E11  -155  Uridine 
Mode of action: N-Source, peptide group: 
PM3B  H01  -119  Ala-Asp 
PM3B  H02  -109  Ala-Gln 
PM3B  H03  -64  Ala-Glu 
PM3B  H04  -87  Ala-Gly 
PM6  B01  -242  Ala-Ser 
PM6  B02  -270  Ala-Th 
PM6  C02  -251  Arg-Phe 
PM6  C03  -263  Arg-Ser 
PM6  C04  -137  Arg-Trp 
PM6  C05  -96  Arg-Tyr 
PM6  D01  -248  Asp-Phe 
PM6  D03  -293  Asp-Val 
PM6  D04  -320  Cys-Gly 
PM6  E01  -252  Glu-Val 
PM6  E02  -268  Gly-Ala 
PM6  E03  -292  Gly-Arg 
PM6  E04  -320  Gly-Cys 
PM6  F02  -254  Gly-Trp 
PM6  F03  -234  Gly-Tyr 
PM6  G03  -260  Ile-Ala 
PM6  G04  -283  Ile-Arg 
PM7  C04  -138  Met-Met 
PM7  C05  -222  Met-Phe 
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PM7  C07  -276  Met-Trp 
PM7  C08  -174  Met-Val 
PM7  D07  -288  Pro-Gly 
PM7  E06  -327  Ser-Phe 
PM7  E07  -335  Ser-Pro 
PM7  E08  -318  Ser-Ser 
PM7  F01  -289  Th-Glu 
PM7  F02  -257  Th-Gly 
PM7  G06  -322  Tyr-Gln 
PM7  G07  -313  Tyr-Glu 
PM7  G08  -265  Tyr-Gly 
PM8  A03  -89  Ala-Asp 
PM8  A06  -238  Ala-Met 
PM8  B01  -276  Gly-Asp 
PM8  B04  -305  His-Glu 
PM8  C04  -233  Met-Tyr 
PM8  C06  -321  Phe-Glu 
PM8  E06  -293  Val-Ala 
PM8  E07  -338  Val-Gln 
PM8  F01  -240  Val-Ser 
PM8  H01  -227  Gly-Gly-Ala 
PM8  H03  -152  Gly-Gly-Gly 
PM8  H05  -138  Gly-Gly-Leu 
PM8  H06  -205  Gly-Gly-Phe 
PM8  H08  -141  Gly-Phe-Phe 
PM8  H11  -170  Phe-Gly-Gly 
PM8  H12  -147  Tyr-Gly-Gly 
 
Note: *Biolog readings: represents the differences between the control bacteria and the treated bacteria. Negative 
values indicate that the control bacteria had greater respiration rate than the treated bacteria. C: carbon, N: nitrogen, 
P: phosphorus and S: sulfur. 
 
Table 4: The profile of suppressed growth of RC-treated S. aureus with the target substrate and 
the implicated metabolic mode of action  
Plate type  Well number  *Biolog reading  Substrate 
Mode of action: C-Source, carbohydrate group: 
PM1  A03  -68  N-Acetyl-D Glucosamine 
PM1  B02  -93  D-Sorbitol 
PM1  B07  -123  D,L-α-Glycerol-Phosphate 
PM1  B11  -58  D-Mannitol 
PM1  C01  -158  D-Glucose-6-Phosphate 
PM1  E03  -135  D-Glucose-1-Phosphate 
PM1  E04  -73  D-Fructose-6-Phosphate 
PM1  H05  -91  D-Psicose 
PM2A  B01  -89  N-Acetyl-D Galactosamine 
PM2A  B03  -185  β-D-Allose 
PM2A  B06  -104  D-Arabitol 
PM2A  D05  -61  Stachyose 
PM2A  E05  -58  D-Glucosamine 
Mode of action: C-Source, carboxylic acid group: 
PM1  B10  -111  Formic Acid 
PM1  D06  -184  α-Keto-Glutaric Acid 
PM1  D03  -85  D-Glucosaminic Acid 
PM1  F05  -93  Fumaric Acid 
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PM1  G07  -81  Acetoacetic Acid 
PM1  G09  -96  Mono Methyl Succinate 
PM1  H02  -127  p-Hydroxy Phenyl Acetic Acid 
PM1  H03  -102  m-Hydroxy Phenyl Acetic Acid 
PM1  H09  -116  L-Galactonic Acid-γ-Lactone 
PM2A  C09  -95  β-Methyl-D Glucuronic Acid 
Mode of action: C-Source, amino acid group: 
PM1  B12  -173  L-Glutamic Acid 
PM1  E01  -108  L-Glutamine 
PM1  F01  -53  Glycyl-L-Aspartic Acid 
PM1  G04  -48  L-Theonine 
PM1  G05  -101  L-Alanine 
PM1  G06  -84  L-Alanyl-Glycine 
PM1  H01  -105  Glycyl-L-Proline 
PM2A  G03  -118  N-Acetyl-Lglutamic Acid 
PM3B  A12  -153  L-Glutamic Acid 
PM3B  B01  -196  L-Glutamine 
PM3B  C03  -204  D-Alanine 
PM6  A02  -211  L-Glutamine 
Mode of action: N-Source, inorganic group: 
PM3B  A02  -84  Ammonia 
PM3B  A03  -69  Nitrite 
Mode of action: Other N-Source group: 
PM3B  E08  -63  D-Glucosamine 
PM3B  E09  -48  D-Galactosamine 
PM3B  F01  -103  N-Acetyl-D Mannosamine 
PM3B  F04  -99  Cytidine 
PM3B  G02  -96  Xanthosine 
Mode of action: P-Source, inorganic group: 
PM4A  A02  -138  Phosphate 
Mode of action: P-Source, organic group: 
PM4A  B02  -146  Dithiophosphate 
PM4A  C01  -93  Phosphoenol Pyruvate 
PM4A  C03  -164  D-Glucose-1-Phosphate 
PM4A  C05  -139  2-Deoxy-D-Glucose 6-Phosphate 
PM4A  C06  -122  D-Glucosamine-6-Phosphate 
PM4A  C07  -94  6-Phospho-Gluconic Acid 
PM4A  D04  -173  Phospho-L Arginine 
PM4A  E01  -144  O-Phospho-D Tyrosine 
PM4A  E02  -89  O-Phospho-Ltyrosine 
Mode of action: S-Source, inorganic group: 
PM4A  B01  -57  Thiophosphate 
PM4A  B02  -96  Dithiophosphate 
PM4A  F02  -168  Sulfate 
PM4A  F03  -182  Thiosulfate 
Mode of action: S-Source, organic group: 
PM4A  G02  -81  S-Methyl-L Cysteine 
PM4A  G03  -89  Cystathionine 
PM4A  G07  -117  L-Methionine 
PM4A  G08  -74  D-Methionine 
Mode of action: Nutritional supplement group: 
PM5  B05  -128  L-Leucine 
PM5  B09  -109  Guanosine-3’,5’- cyclic 
Monophosphate 
PM5  A03  -117  L-Alanine 
PM5  A04  -91  L-Arginine 
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PM5  C10  -92  Hypoxanthine 
PM5  D10  -66  Cytosine 
PM5  D11  -152  Cytidine 
PM5  E03  -126  Spermine 
PM5  E06  -216  Pyridoxamine 
PM5  E08  -203  D-Pantothenic Acid 
PM5  E10  -158  Uracil 
PM5  E11  -119  Uridine 
Mode of action: N-Source, peptide group: 
PM3B  H02  -95  Ala-Gln 
PM3B  H03  -74  Ala-Glu 
PM3B  H04  -114  Ala-Gly 
PM6  B05  -179  Arg-Ala 
PM6  B06  -238  Arg-Arg 
PM6  C02  -216  Arg-Phe 
PM6  C03  -219  Arg-Ser 
PM6  C04  -203  Arg-Trp 
PM6  C05  -142  Arg-Tyr 
PM6  C11  -95  Asp-Leu 
PM6  C12  -78  Asp-Lys 
PM6  E01  -177  Glu-Val 
PM6  E02  -164  Gly-Ala 
PM6  E03  -199  Gly-Arg 
PM6  E04  -219  Gly-Cys 
PM6  F02  -174  Gly-Trp 
PM6  F03  -221  Gly-Tyr 
PM6  G03  -219  Ile-Ala 
PM6  G04  -153  Ile-Arg 
PM7  A06  -175  Lys-Ala 
PM7  A07  -185  Lys-Arg 
PM7  B03  -147  Lys-Th 
PM7  B05  -217  Lys-Tyr 
PM7  B07  -201  Met-Arg 
PM7  B09  -174  Met-Gln 
PM7  D07  -275  Pro-Gly 
PM7  E06  -127  Ser-Phe 
PM7  E07  -195  Ser-Pro 
PM7  E08  -139  Ser-Ser 
PM7  F06  -228  Trp-Ala 
PM7  F07  -291  Trp-Arg 
PM7  G06  -143  Tyr-Gln 
PM7  G07  -94  Tyr-Glu 
PM7  G08  -89  Tyr-Gly 
PM8  A03  -91  Ala-Asp 
PM8  A06  -153  Ala-Met 
PM8  B01  -193  Gly-Asp 
PM8  B04  -207  His-Glu 
PM8  C07  -143  Gln-Glu 
PM8  C08  -129  Phe-Met 
PM8  H01  -194  Gly-Gly-Ala 
PM8  H03  -189  Gly-Gly-Gly 
PM8  H05  -85  Gly-Gly-Leu 
PM8  H06  -192  Gly-Gly-Phe 
PM8  H08  -122  Gly-Phe-Phe 
Note: *Biolog readings: represents the differences between the control bacteria and the treated bacteria. Negative 
values indicate that the control bacteria had greater respiration rate than the treated bacteria. C: carbon, N: nitrogen, 
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DISCUSSION: 
RC extract showed bacteristatic effect on E. coli (ATCC 25922) and S. aureus (ATCC 29247); 
this enabled the detection of any inhibition in the cell growth by monitoring the changes in the 
level  of  respiration  between  treated  and  untreated  cells.  The  selected  bacteria  were  used  as 
representatives for elucidating the phenotypic and biochemical profiling of Gram positive and 
negative bacteria treated with RC extract. The results of PM analysis of E. coli and S. aureus 
treated cells provided a good example for RC antimicrobial activity when compared with PM 
results of untreated cells. Both Gram positive and negative bacteria showed similar response to 
RC extract, up to 80% similarity. This granted clue on the common antibacterial mechanisms 
pursued by RC extract on both Gram negative and positive bacteria. Moreover, there was a very 
good agreement to the results obtained by SEM and TEM observations. The PM results showed 
that RC extract had a clear ability to inhibit bacterial growth by direct effect on the assimilation 
of different metabolites. PM readings for untreated cells showed that these cells grew normally 
in PM plates while PM readings for treated cells indicated clear defects in the growth of bacteria 
using  peptide  metabolism  pathways.  The  other  clear  defect  was  detected  in  the  metabolism 
pathways of carbon source metabolites. The detected features by SEM and TEM observations 
that were characterized by changes in cell wall, which may be due to an increase in cell wall 
permeability, could be explained by the defect in the peptide metabolic pathways. RC extract 
affected this pathway more than other pathways in a significant way. Peptidoglycan is composed 
of peptides (like L-alanine and D-alanine) plus glycan chain (polysaccharide, like N-acetyl D 
glucosamin), [29]. Moreover, peptidoglycan prevents bacteria from undergoing an osmotic lyses. 
Therefore, it is an ideal target for selective toxicity [30]. The results showed that RC extract 
inhibited the assimilation of N-acetyl D glucosamin together with L- and D-alanine. Therefore, 
RC  extract  could  be  a  highly  promising  antibacterial  agent  that  can  hit  bacteria  at  targets 
different  from  those  hit  by  commercially  available  drugs.  For  example,  the  beta-lactam 
antibiotics like penicillin and apmicillin inhibit bacterial growth by binding to and inhibiting 
enzymes needed for the synthesis of the peptidoglycan wall [31]. Cycloserine is an analog of D-
alanine and blocks the incorporation of D-alanine into the peptide bridges in the bacterial cell 
wall [32]. Additionally, RC extract was shown to inhibit the utilization of sulfur metabolite 
pathways. Sulfur is an essential component of cells [29]. In E. coli, among the 4,500 genes in the 
genome, more than one hundred genes are directly involved in some steps of sulfur metabolism 
[33].  Besides,  sulfur  metabolic  pathways  of  pathogenic  bacteria  hold  importance  for  its 
biological implications as well as the presence of potential enzymes that act as good targets for 
many  future  antimicrobial  drugs  [34].  Therefore,  sulfur  pathways  affected  by  RC  extract 
represent an additional target signifying the importance of RC extract as a candidate for new 
drug(s) against new targets in both Gram positive and negative bacteria. Furthermore, RC extract 
showed significant inhibition to the metabolic pathways that utilize other nitrogen sources and 
nutritional supplement. The blocking of these pathways may give an overview on the effective 
antibacterial activity of RC extract in this study. However, it is not known whether single or 
multiple  antibacterial  components  in  RC  extract  are  responsible  for  the  currently  shown 
phenotypic profiling, but the wide range of metabolic pathways affected by RC extract suggested 
strongly  that  more  than  one  component  shares  the  antibacterial  activity  of  RC  extract. 
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responsible antibacterial components as well as provided a metabolic guide, or metabolic finger 
print, for the future work on isolating and testing the function of the antibacterial components 
observed in RC extract.      
 
CONCLUSION: 
It  was  concluded that RC extract  using acid  methanol  solvent  provided potent antimicrobial 
effects against the tested Gram negative and Gram positive bacteria. RC extract showed that it is 
capable of hitting a wide range of metabolic pathways which were clarified through using state-
of-the-art Biolog Phenotype Microarray. RC inhibited bacterial growth through peptide, carbon, 
nd  sulfur–based  pathways  of  bacterial  growth.  Hence,  this  study  acts  as  a  comprehensive 
platform for further studies to elucidate the components responsible for such remarkable and 
broad antibacterial mechanisms found in RC. Moreover, the phenotypic profiling of antibacterial 
activity of RC have shown that using extracts of functional foods or medicinal plants might be 
more robust in counteracting microbial resistance against antimicrobials. This phenomenon is 
explained  by  that  extracts  of  functional  food  or  medicinal  plants  possess  a  wide  range  of 
components that act in parallel or in synergistic way in exerting the antibacterial effect. RC 
extract was found to be an excellent example of the potency hidden in using certain functional 
foods  as  such  or  as  extracts  in  combating  bacteria  without  fearing  of  rapid  development  of 
bacterial  resistance  due  to  the  lack  of  mono-acting  antibacterial  effect  in  these  extracts. 
Therefore, this study serves as the current endeavor to find potent natural antibacterial products 
from functional food as we are heading consistently to the post-antibiotic era due to the ever 
increasing microbial resistance against current antibiotics. 
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